ATS PC Assembly retweeted
A CHEST Review synthesizes guideline recommendations and contemporary real-world evidence, emphasizing diagnostic pitfalls, potential causes of anticoagulation failure, and practical strategies for treatment adjustment in recurrent VTE.
Read more in the October issue of the journal CHEST®: hubs.la/Q04zVdBF0
#MedEd #JournalCHEST
How Wearable Tech and Remote Walk Tests Are Changing PAH Care
@phaware® podcast Episode 596 - Daniel Lachant, MD
phaware.global/ph-stories/ph…
ATS PC Assembly retweeted
The Health Equity & Diversity Hub is a dynamic, welcoming space for professionals committed to advancing health equity, diversity, inclusion, and belonging across health care, research, education, and communities at ATS.
We are thrilled to extend an invitation to you to propose a session for our “Studio Talks” at the ATS Networking Super Center, during the ATS International Conference scheduled for May 14-19 in New Orleans. For more information and to apply, email [email protected]
ATS PC Assembly retweeted
Anjali Vaidya, MD, explains why echocardiography should inform right heart catheterization interpretation in pulmonary hypertension at #CHEST2026. Watch now:
hcplive.com/view/pair-echo-r…
ATS PC Assembly retweeted
Expert Insights, from Guidelines to the Real World: The incidence of PVOD found in BOTH scleroderma PH-ILD and scleroderma PAH is high (from lung explant study at journal.chestnet.org/article…). #CHEST2026 #CHESTSoMe @accpchest @CHESTPulmCardio @SandeepSahayMD
ATS PC Assembly retweeted
Expert Insights, from the Data to the Real World: Pregnancy in PAH—confirmation of hemodynamics, optimization of PH therapy, and COUNSELING throughout! #CHEST2026 #CHESTSoMe @accpchest @CHESTPulmCardio
ATS PC Assembly retweeted
Expert Insights, from Data to Real World: POPH — Can be due to portal hypertension, cirrhotic or non-cirrhotic. Pay close attention to hemodynamics, an otherwise “normal” CO is often relatively low for portal hypertension patients who usually have hyperdynamic CO at baseline. #CHEST2026 #CHESTSoMe @accpchest @CHESTPulmCardio
ATS PC Assembly retweeted
💡 High-yield POCUS algorithm for acute Right Ventricular Failure from #CHEST2026:
Key diagnostic checkpoints at the bedside:
🔹 RV:LV ratio ≥1.0 (Apical 4-chamber)
🔹 Septal flattening / D-shaped LV in PSAX (pressure/volume overload)
🔹 Reduced TAPSE (< 1.7 cm) & RV free wall S' (< 9.5 cm/s})
🔹 Dilated IVC (> 2.1 cm) with < 50% collapse
Integrate these findings early when managing shock!
#DrSarangPatil #CHEST2026 #POCUS #CriticalCare #CardioPulm
ATS PC Assembly retweeted
📢 Just one week to go!
8th International Leh Symposium 2026
📍 McLeod Ganj, Dharamshala, India
🗓 23-27 October 2026
Join the global PH community to explore the latest research on therapeutic targets and molecular mechanisms for pulmonary diseases in hypoxia.
Highlights include:
▪️cutting-edge science in hypoxia and pulmonary disease
▪️international experts in research and clinical care
▪️opportunities for collaboration and scientific exchange
▪️discussions on advancing prevention and treatment strategies
➡️ Register here: lehsymposium.in/
ATS PC Assembly retweeted
Who do you think would make an excellent PVRI President? 🏆💡 Nominations are open for two more weeks for PVRI President 2028-30 and for PVRI Achievement Awards 2026.
Help us celebrate the people shaping PH research, care & collaboration around the world. ➡️ Nominate: pvrinstitute.org/learning-hu…
Nominations close: 28 October, 09:00 GMT
ATS PC Assembly retweeted
In recognition of World Thrombosis Day on October 13, CHEST joins the global effort to raise awareness of thrombosis and its prevention.
Explore a special feature from journal CHEST® reviewing key recommendations for antithrombotic therapy in venous thromboembolism (VTE) from three CHEST guidelines.
Read more: hubs.la/Q04zRKYs0
ATS PC Assembly retweeted
What can blood biomarkers tell us about PAH? 🩸
Blood Biomarkers in Pulmonary Arterial Hypertension – New Insights
📅 12 November 2026
🕓️ 16:00 - 17:00 GMT
You'll hear the latest research on:
▪️biomarker validation for clinical use
▪️plasma proteome risk stratification
▪️NOTCH3-ECD as a biomarker for PAH
▪️novel predictors of outcomes in PAH
▪️markers of vascular dysfunction
➡️ Register now: pvrinstitute.org/learning-hu…
ATS PC Assembly retweeted
Got an idea for #ATS2027?
We're seeking proposals for the ATS Networking Super Center Learning Studio! Submit ideas for networking events, interactive workshops, presentations, or small-group discussions.
#CareerDevelopment
Submit a proposal today: bit.ly/4vUn1Y7
ATS PC Assembly retweeted
INSIDE LOOK 👀 Read more of the latest research from the upcoming issue (October 8): What factors are associated with higher mean pulmonary arterial pressure after balloon pulmonary angioplasty?
Read the original research in the October issue of the journal CHEST®: hubs.la/Q04xZBzF0
#MedEd #JournalCHEST
ATS PC Assembly retweeted
We are recruiting for ECP teachers!
ATS is seeking volunteers to teach at the ATS 2027 Early Career Professional (ECP) Programs in New Orleans, May 14-15, 2027
📅Apply by October 30, 2026
✉️Assignments will be emailed in January 2027
👉Interested? bit.ly/3SveFHS
ATS PC Assembly retweeted
Ecstatic to share our latest work in @CircRes aimed at understanding RV dysfunction. Multi-omics analyses nominated underexplored pathways in severe RV dysfunction. ahajournals.org/doi/full/10.…. @Jenna_Mendelson @MadelynJBlake @MUSC_IM @PVRI @ATS_PC
ATS PC Assembly retweeted
In the Top PE Papers session, Dr. @GregoryPiazza4 presents the results of the exciting #HIPRO trial, showing that low-dose apixaban reduced the rate of recurrent VTE at 12 months in patients with provoked VTE #pert2026
ATS PC Assembly retweeted
We’re fortunate to have several new studies from 2025 helping inform our decisions on extended-duration, reduced-dose DOACs in higher-risk VTE populations, where balancing recurrence and bleeding risk remains critical. #PERT2026
ATS PC Assembly retweeted
What’s next?! Dr Mae West sharing what’s on the horizon of RCTs for PE with interventions ranging from all forms of catheter-directed therapies to systemic thrombolysis with real and patient-centered outcomes. #PE-Tract #PIETHO-3 #PEERLESSII
ATS PC Assembly retweeted
Number needed to treat of 16 to prevent worsening clinical status for EKOS in intermediate risk PE compared to AC alone with no additional significant bleeding risk - Dr Ken Rosenfield #HI-PIETHO






























